RNA markers for antidepressant response in depression
Treatments studied
Part of Mental health clinical trials.
This study looks at how RNA might help predict which antidepressant works best for you. It tests two medications: vortioxetine and cariprazine, in people with major depressive disorder or bipolar depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are currently experiencing a major depressive episode as part of major depressive disorder, bipolar I disorder, or bipolar II disorder.
- Your depression symptoms are at least moderate (score over 10 on a standard questionnaire).
- You can travel to the clinic for study visits.
- If you are a woman who could become pregnant, you must have a negative pregnancy test and use an effective birth control method.
- For bipolar I disorder, you must be on a stable dose of a mood stabilizer for at least one month before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.
This study uses a blood test (biomarker) to help pick the antidepressant that might work best for you. It compares two treatments—standard antidepressants and ketamine—in people with major depression who haven't gotten enough relief from one prior treatment.
This trial is looking for people with major depression to study how genes and other markers might help doctors choose the best medication. The goal is to make depression treatment more precise and effective.
This study looks at treatment response markers (signs in the body) in people with major depressive disorder (MDD). It may help researchers understand who is more likely to benefit from antidepressant treatment.
This study tests whether certain immune markers and mood symptoms can help predict how well people will respond to antidepressants. Researchers hope to make treatment more personalized for people with depression.
This study looks at whether a genetic test can help choose the best antidepressant for you. It aims to make treatment more personalized and effective for people with depression.
Hear when a new Bipolar Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.